Director of the Infectious Disease Research Center, Goodrich has been investigating vaccine candidates to combat the virus that causes COVID-19.
Goodrich has worked in infectious disease research for over 29 years, during which he has managed research staff and development programs in the fields of transfusion and transplantation medicine and pathogen reduction technologies. He has been awarded over 50 patents covering technology in these areas and has co-authored over 200 peer reviewed articles and abstracts.
Goodrich is an active member of the American Chemical Society, the American Association of Blood Banks and the International Society of Blood Transfusion. He remains an adjunct professor of chemistry at Ohio State University, and has lectured and taught for over 20 years.
Goodrich received his Ph.D. in biophysical chemistry from the California Institute of Technology in Pasadena, California.